RAVELLI, ANDREA
RAVELLI, ANDREA
Dipartimento di Medicina e Chirurgia
CDK4/6 inhibitors in HER2-positive breast cancer
2017-01-01 Corona, Silvia Paola; Ravelli, Andrea; Cretella, Daniele; Cappelletti, Maria Rosa; Zanotti, Laura; Dester, Martina; Gobbi, Angela; Petronini, Pier Giorgio; Generali, Daniele
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.
2017-01-01 Bonelli, Mara; Digiacomo, Graziana; Fumarola, Claudia; Alfieri, Roberta; Quaini, Federico; Falco, Angela; Madeddu, Denise; LA MONICA, Silvia; Cretella, Daniele; Ravelli, Andrea; Ulivi, P; Tebaldi, M; Calistri, D; Delmonte, A; Ampollini, Luca; Carbognani, Paolo; Tiseo, Marcello; Cavazzoni, Andrea; Petronini, Pier Giorgio
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN
2017-01-01 Cavazzoni, Andrea; La Monica, Silvia; Alfieri, Roberta; Ravelli, Andrea; Steen, Nele Van Der; Sciarrillo, Rocco; Madeddu, Denise; Lagrasta, Costanza Anna Maria; Quaini, Federico; Bonelli, Mara; Fumarola, Claudia; Cretella, Daniele; Digiacomo, Graziana; Tiseo, Marcello; Peters, Godefridus J.; Ardizzoni, Andrea; Petronini, Pier Giorgio; and Elisa, Giovannetti
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
2018-01-01 Cretella, Daniele; Ravelli, Andrea; Fumarola, Claudia; LA MONICA, Silvia; Digiacomo, Graziana; Cavazzoni, Andrea; Alfieri, Roberta; Biondi, Alessandra; Generali, Daniele; Bonelli, Mara; Petronini, Pier Giorgio
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility
2017-01-01 Ravelli, A; Roviello, G; Cretella, D; Cavazzoni, A; Biondi, A; Cappelletti, M; Zanotti, L; Ferrero, G; Ungari, M; Zanconati, F; Bottini, A; Alfieri, R; Petronini, Pg; Generali, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| CDK4/6 inhibitors in HER2-positive breast cancer | 1-gen-2017 | Corona, Silvia Paola; Ravelli, Andrea; Cretella, Daniele; Cappelletti, Maria Rosa; Zanotti, Laura; Dester, Martina; Gobbi, Angela; Petronini, Pier Giorgio; Generali, Daniele | |
| Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. | 1-gen-2017 | Bonelli, Mara; Digiacomo, Graziana; Fumarola, Claudia; Alfieri, Roberta; Quaini, Federico; Falco, Angela; Madeddu, Denise; LA MONICA, Silvia; Cretella, Daniele; Ravelli, Andrea; Ulivi, P; Tebaldi, M; Calistri, D; Delmonte, A; Ampollini, Luca; Carbognani, Paolo; Tiseo, Marcello; Cavazzoni, Andrea; Petronini, Pier Giorgio | |
| Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN | 1-gen-2017 | Cavazzoni, Andrea; La Monica, Silvia; Alfieri, Roberta; Ravelli, Andrea; Steen, Nele Van Der; Sciarrillo, Rocco; Madeddu, Denise; Lagrasta, Costanza Anna Maria; Quaini, Federico; Bonelli, Mara; Fumarola, Claudia; Cretella, Daniele; Digiacomo, Graziana; Tiseo, Marcello; Peters, Godefridus J.; Ardizzoni, Andrea; Petronini, Pier Giorgio; and Elisa, Giovannetti | |
| The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells | 1-gen-2018 | Cretella, Daniele; Ravelli, Andrea; Fumarola, Claudia; LA MONICA, Silvia; Digiacomo, Graziana; Cavazzoni, Andrea; Alfieri, Roberta; Biondi, Alessandra; Generali, Daniele; Bonelli, Mara; Petronini, Pier Giorgio | |
| Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility | 1-gen-2017 | Ravelli, A; Roviello, G; Cretella, D; Cavazzoni, A; Biondi, A; Cappelletti, M; Zanotti, L; Ferrero, G; Ungari, M; Zanconati, F; Bottini, A; Alfieri, R; Petronini, Pg; Generali, D. |